The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-2-((benzo[d]thiazol-5-ylimino)methyl)-3,4-dibromo-6-ethoxyphenol ID: ALA3335254
PubChem CID: 136044163
Max Phase: Preclinical
Molecular Formula: C16H12Br2N2O2S
Molecular Weight: 456.16
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCOc1cc(Br)c(Br)c(/C=N/c2ccc3scnc3c2)c1O
Standard InChI: InChI=1S/C16H12Br2N2O2S/c1-2-22-13-6-11(17)15(18)10(16(13)21)7-19-9-3-4-14-12(5-9)20-8-23-14/h3-8,21H,2H2,1H3/b19-7+
Standard InChI Key: BZOMOAATOQLIJB-FBCYGCLPSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
16.9780 -8.3411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9769 -9.1606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6849 -9.5696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3946 -9.1602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3917 -8.3375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6831 -7.9322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0979 -7.9262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8071 -8.3322 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.5133 -7.9209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2210 -8.3302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2098 -6.6958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5070 -7.1088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9240 -7.1016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9261 -7.9165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7017 -8.1665 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.1792 -7.5059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6984 -6.8479 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
19.1029 -9.5676 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.6847 -10.3868 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.3923 -10.7956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2702 -7.9327 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
17.6807 -7.1150 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
19.1001 -10.3871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 14 1 0
13 11 1 0
11 12 2 0
12 9 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 13 1 0
4 18 1 0
3 19 1 0
19 20 1 0
1 21 1 0
6 22 1 0
20 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 456.16Molecular Weight (Monoisotopic): 453.8986AlogP: 5.68#Rotatable Bonds: 4Polar Surface Area: 54.71Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 8.31CX Basic pKa: 2.09CX LogP: 5.42CX LogD: 5.37Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.51Np Likeness Score: -1.15
References 1. Shim HJ, Yang HR, Kim HIe, Kang SA, No KT, Jung YH, Lee ST.. (2014) Discovery of (E)-5-(benzylideneamino)-1H-benzo[d]imidazol-2(3H)-one derivatives as inhibitors for PTK6., 24 (19): [PMID:25205190 ] [10.1016/j.bmcl.2014.08.036 ]